Physician Finder

Promaxo MRI System & Robot* for Targeted Prostate Interventions

Leading the way in precision diagnostics and treatment.

Contact Us to Learn More

The Power of Advanced Imaging, AI, and Robotics*

At Promaxo, we’re transforming prostate cancer care. Our groundbreaking ecosystem of advanced imaging, artificial intelligence, and robotics* sets a new gold standard in precision diagnostics and treatment. With Promaxo’s cutting-edge system, physicians can now easily identify and target prostate cancer with unparalleled ease and unprecedented accuracy, ushering in a new era of confident, precision care.

Achieve Better Results with Promaxo MRI System

Promaxo MRI System

Learn More

Promaxo AI

Learn More

Promaxo Robot*

Learn More
Did You Know?
The Promaxo MRI System is protected by over 250 patents.
Did You Know?
Promaxo has the world’s first single-sided interventional MRI.
Did You Know?
Advanced AI algorithms are used for real-time intra-operative planning.

Target Only
What Matters

By leveraging advanced imaging, artificial intelligence, and robotics*, physicians can now identify prostate cancer with a higher degree of accuracy and precision. This capability allows practitioners to easily return to the same location for targeted treatment, paving the way for more focal therapy options, improving confidence in clinical outcomes, and reducing the risk of overtreatment.

Learn How Our Technology Can Help You

Contact Now

1 Price, John H., et al. “Accurate Prostate Biopsies Using Low-Field Portable Intervention MRI in an Ambulatory Surgical Center.” IPCU, 2024.
2 Sze, C., et al (2023). “Feasibility and preliminary clinical tolerability of low-field MRI-guided prostate biopsy.” The Prostate, 83(7), 656-662. https://doi.org/10.1002/pros.24499.
3 Sze, C., et al, (2022) “Cost-efficient analysis of a portable low field magnetic resonance imaging system for prostate cancer diagnosis.” Front.
Urol.2:966862. doi: 10.3389/fruro.2022.966862.
4 Chiragzada, S., et al. “Advantageous Detection of Significant Prostate Cancer Using a Low-Field, Office-Based MRI System.” Cureus. 2022 Dec 1;14(12):e32105. doi:10.7759/cureus.32105. PMID:
36601170; PMCID: PMC9805358.
5 Data on file.
6 Xiang, Jianjian, et al. “Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: A systematic review and meta-analysis.ˮ World Journal of Surgical Oncology, vol. 17, no. 1,13 Feb. 2019, https://doi.org/10.1186/s12957-019-1573-0.
*The Promaxo Robot is not yet available for commercial sale.

Linkedin-in Youtube X-twitter Facebook-f

© 2024 Promaxo, Inc. All rights reserved.

Scroll to Top

The Promaxo MRI System features a unique single-sided design that provides unparalleled accessibility for both physicians and patients in various clinical settings. This innovative platform technology enhances usability and opens possibilities for guiding precision-targeted procedures for different parts of the body in the future.

Promaxo uses proprietary imaging, AI denoising, and advanced reconstruction techniques to create 3D visualizations for real-time intraoperative planning and guidance.

The Promaxo Robot* leverages real-time imaging and AI to automate and enhance the precision of prostate biopsies and cancer treatments. This advanced technology enables urologists to provide more accurate, personalized care to their patients.